Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation

AC Anderson, N Joller, VK Kuchroo - Immunity, 2016 - cell.com
Co-inhibitory receptors, such as CTLA-4 and PD-1, have an important role in regulating T
cell responses and have proven to be effective targets in the setting of chronic diseases …

Tim-3, lag-3, and TIGIT

N Joller, VK Kuchroo - … concepts targeting immune checkpoints in cancer …, 2017 - Springer
Co-inhibitory receptors play a key role in regulating T cell responses and maintaining
immune homeostasis. Their inhibitory function prevents autoimmune responses but also …

Co-inhibitory pathways and their importance in immune regulation

N Murakami, LV Riella - Transplantation, 2014 - journals.lww.com
Immune regulation is critical for the maintenance of peripheral self-tolerance and for down-
regulation of immune responses. Understanding its mechanisms may permit the …

Inhibitory receptor agonists: the future of autoimmune disease therapeutics?

S Grebinoski, DAA Vignali - Current opinion in immunology, 2020 - Elsevier
Highlights•Inhibitory receptors (IRs) play an important role in limiting autoimmunity.•IR
genetic deletion or antibody blockade exacerbates autoimmunity in mouse models.•SNPs …

Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization

L Baitsch, A Legat, L Barba, SA Fuertes Marraco… - PloS one, 2012 - journals.plos.org
Inhibitory receptors mediate CD8 T-cell hyporesponsiveness against cancer and infectious
diseases. PD-1 and CTLA-4 have been extensively studied, and blocking antibodies have …

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity

A Schnell, L Bod, A Madi, VK Kuchroo - Cell research, 2020 - nature.com
Co-inhibitory receptors are important regulators of T-cell function that define the balance
between tolerance and autoimmunity. The immune regulatory function of co-inhibitory …

Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation

TK Maeda, D Sugiura, I Okazaki, T Maruhashi… - Journal of Biological …, 2019 - ASBMB
T cell activation is tightly regulated by both stimulatory and inhibitory co-receptors and has
been a focus in the development of interventions for managing cancer or autoimmune …

Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups

LP Andrews, H Yano, DAA Vignali - Nature immunology, 2019 - nature.com
Although immunotherapeutics targeting the inhibitory receptors (IRs) CTLA-4, PD-1 or PD-
L1 have made substantial clinical progress in cancer, a considerable proportion of patients …

LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation

N Joller, AC Anderson, VK Kuchroo - Immunity, 2024 - cell.com
Summary LAG-3, TIM-3, and TIGIT comprise the next generation of immune checkpoint
receptors being harnessed in the clinic. Although initially studied for their roles in restraining …

LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII

T Maruhashi, I Okazaki, D Sugiura, S Takahashi… - Nature …, 2018 - nature.com
The success of tumor immunotherapy targeting the inhibitory co-receptors PD-1 and CTLA-4
has indicated that many other co-receptors might be potential druggable targets, despite …